Weight and skeletal muscle loss with cabozantinib in metastatic renal cell carcinoma

• मुख्य लेखकों: Emeline Colomba (लेखक), Carolina Alves Costa Silva (लेखक), Gwénaël Le Teuff (लेखक), Jamie Elmawieh (लेखक), Daniel Afonso (लेखक), Axelle Benchimol‐Zouari (लेखक), Annalisa Guida (लेखक), Lisa Derosa (लेखक), Ronan Flippot (लेखक), Bruno Raynard (लेखक), Bernard Escudier (लेखक), François Bidault (लेखक), Laurence Albiges (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: Wiley, 2022-10-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

Abstract Background Cabozantinib, a standard of care metastatic renal cell carcinoma (mRCC), may be associated with weight and muscle loss. These effects of new generation VEGFR tyrosine kinase inhibitor on muscle mass loss are poorly described. Methods All cabozantinib‐treated mRCC patients from Ja...